Diagnostic Evaluation of Urinary Incontinence in Geriatric Patients

Am Fam Physician. 1998 Jun 1;57(11):2675-2684.

  See related patient information handout on urinary incontinence, written by Elizabeth S. Smoots, M.D., Seattle, Wash.

In most cases, the evaluation of urinary incontinence requires only a history, a physical examination, urinalysis and measurement of postvoid residual urine volume. The initial purposes of the evaluation are to identify conditions requiring referral or specialized work-up and to detect and treat reversible causes that may be present. If the patient does not appear to require referral and a reversible cause is not identified, the next step is to categorize the patient's symptoms as typical of either urge or stress incontinence and treat the patient accordingly. If treatment fails or a presumptive diagnosis of urge or stress incontinence cannot be reached, the final step would be to perform more sophisticated tests or refer the patient for testing to define the cause and determine the best treatment.

Urinary incontinence, the unintentional leakage of urine at inappropriate times, is a classic syndrome in geriatric medicine. It affects approximately 13 million persons in the United States, most of whom are older adults.1 This article describes the evaluation of urinary incontinence in geriatric patients, focusing on a diagnostic approach for use by primary care physicians. A more detailed discussion of the diagnosis and management of urinary incontinence can be found in the revised clinical practice guideline recently published by the U.S. Agency for Health Care Policy and Research (AHCPR).1

Prevalence

Studies on the prevalence of incontinence have yielded varying results, largely because each study has used different populations and criteria to define incontinence.26  Overall, however, estimates indicate that about one half of the homebound and institutionalized elderly are incontinent, as are 25 to 30 percent of older patients discharged after hospitalization for acute medical illnesses. Among community-dwelling, ambulatory, non-homebound persons over 60 years of age, approximately 10 to 15 percent of men and 20 to 35 percent of women have incontinent episodes. Continuous or daily incontinence occurs in about 5 percent of community-dwelling older persons (Table 1).26

TABLE 1

Prevalence of Any Degree of Urinary Incontinence

Population subgroup Approximate prevalence (%)

Nursing home residents (age over 65 years)

50

Homebound elderly persons (age over 65 years)

50

Hospitalized elderly persons (age over 65 years)

25 to 30

Community-dwelling older women (age over 60 years)

25 to 35

Community-dwelling older men (age over 60 years)

10 to 15

Younger adult women (age 15 to 64 years)

10 to 30

Younger adult men

1 to 5

(age 15 to 64 years)


Information from references 2 through 6.

TABLE 1   Prevalence of Any Degree of Urinary Incontinence

View Table

TABLE 1

Prevalence of Any Degree of Urinary Incontinence

Population subgroup Approximate prevalence (%)

Nursing home residents (age over 65 years)

50

Homebound elderly persons (age over 65 years)

50

Hospitalized elderly persons (age over 65 years)

25 to 30

Community-dwelling older women (age over 60 years)

25 to 35

Community-dwelling older men (age over 60 years)

10 to 15

Younger adult women (age 15 to 64 years)

10 to 30

Younger adult men

1 to 5

(age 15 to 64 years)


Information from references 2 through 6.

Although urinary incontinence is common, it frequently is not identified because fewer than 50 percent of affected patients report the problem to their physicians.7 Many patients believe incontinence is a normal result of aging—that nothing can be done about it or that nothing can be done except surgery (and they are not interested in surgery).8 Thus, if urinary incontinence is to be detected, often physicians must ask about it.

Implications of Incontinence

Urinary incontinence has important medical, psychosocial and economic implications. Medically, incontinence is associated with decubitus ulcers, urinary tract infections, sepsis, renal failure and increased mortality. The social implications of incontinence include loss of self-esteem, restriction of social and sexual activities, depression and, in severe cases, dependence on caregivers.9 Incontinence is often a key factor in the decision to place elderly persons in nursing homes. In the United States, the cost of managing urinary incontinence and its complications exceeds $1.5 billion per year.10

Physiology of Micturition

The physiologic systems that control micturition (urination) are quite complex. However, family physicians with a general understanding of the detrusor and sphincter mechanisms can manage most patients with urinary incontinence.

Detrusor Mechanism

The detrusor muscle is the multilayered contractile muscle of the urinary bladder. The detrusor mechanism involves the detrusor muscle, the pelvic nerves, the spinal cord and the cerebral centers that control micturition. When a person's bladder begins to fill with urine, neural impulses are transmitted through the pelvic nerves and spinal cord to subcortical and cortical cerebral centers. The subcortical centers (in the basal ganglia and the cerebellum) cause the bladder to relax (subconsciously) so that it can fill without causing the person to experience an urge to void. As filling continues, the sensation of bladder distention reaches consciousness, and the cortical centers (in the frontal lobe) permit volitional delay of urination. Impairment of these cortical or subcortical centers by medication or disease can diminish the ability to postpone urination.

When urination is desired, neural impulses from the cortex are transmitted through the spinal cord and pelvic nerves to the detrusor muscle. The cholinergic action of the pelvic nerves then causes the detrusor muscle to contract and the bladder to empty. Interference with the cholinergic activity of the pelvic nerves results in diminished contractility of this muscle.

Detrusor muscle contraction does not depend solely on cholinergic innervation by the pelvic nerves. The detrusor muscle also contains receptors for prostaglandins. Hence, prostaglandin-inhibiting drugs can impair detrusor contractions. Bladder contractions are also calcium channel dependent. Therefore, calcium channel blockers can also impair bladder contractions.

Sphincter Mechanism

Innervation of the internal and external urethral sphincters is also complex. However, to prescribe effective medications for the treatment of incontinence, family physicians need to understand the basic adrenergic innervation of these sphincters as well as the anatomic relationships of the urethra and the bladder.

Alpha-adrenergic activity causes the urethral sphincter to contract. Therefore, medications with alpha-adrenergic agonist activity (e.g., pseudoephedrine) can strengthen sphincter contractions, whereas alpha-blocking agents (e.g., terazosin [Hytrin]) can impair sphincter closure. Beta-adrenergic innervation causes relaxation of the urethral sphincter. Therefore, beta-adrenergic blocking agents (e.g., propranolol [Inderal]) can interfere with urethral relaxation and leave alpha-adrenergic contractile activity unopposed.

The other important component of the sphincter mechanism is the anatomic relationship of the urethra to the bladder and the abdominal cavity. A continent sphincter mechanism requires proper angulation between the urethra and the bladder. Normal urethral sphincter function also depends on proper positioning of the urethra so that increases in intra-abdominal pressure are effectively transmitted to the urethra. When the urethra is in the correct position, urine is not lost with straining, coughing and other maneuvers that increase intra-abdominal pressure.

Basic Mechanisms

Three basic mechanisms serve as “final common pathways” in nearly all causes of incontinence: (1) urge incontinence, also referred to as “hyperactive bladder” or “irritable bladder,” (2) stress incontinence, which results from poor urethral sphincter function (primary urethral incompetence) and (3) overflow bladder.

Urge incontinence is a common problem that increases in frequency and severity with advancing age and cognitive dysfunction. Overall, however, stress incontinence is the most prevalent form of incontinence in geriatric patients, largely because women predominate in this group.11,12 Many elderly persons, particularly women, have “mixed incontinence,” in which urge and stress incontinence coexist.13

Overflow bladder is relatively uncommon. However, it is an important problem because without treatment it can lead to hydronephrosis and renal damage. Urinary incontinence due to overflow bladder is more common in men because of the prevalence of obstructive prostate gland enlargement.

Urge Incontinence

Urge incontinence results from bladder contractions that overwhelm the ability of the cerebral centers to inhibit them. These uncontrollable contractions can occur because of inflammation or irritation within the bladder resulting from calculi, malignancy, infection or atrophic vaginitis-urethritis. They can also occur when the brain centers that inhibit bladder contractions are impaired by neurologic conditions such as stroke, Parkinson's disease or dementia, drugs such as hypnotics or narcotics, or metabolic disorders such as hypoxemia and encephalopathy.

Patients with uncontrolled bladder contractions can also develop incontinence when high urine volumes are introduced rapidly into the bladder (e.g., diuretic therapy, glycosuria-induced osmotic diuresis). Finally, urge incontinence can occur when mobility is impaired (for example, in patients with arthritis), making it difficult for patients to get to the bathroom in time. This condition is sometimes referred to as “functional” incontinence.

Stress Incontinence

Stress incontinence is caused by a malfunction of the urethral sphincter that causes urine to leak from the bladder when intra-abdominal pressure increases, such as during coughing or sneezing. Classic or genuine stress incontinence is caused by pelvic prolapse, urethral hypermobility or displacement of the urethra and bladder neck from their normal anatomic alignment. Stress incontinence can also occur as a result of intrinsic sphincter deficiency, in which the sphincter is weak because of a congenital condition or denervation resulting from alpha-adrenergic blocking drugs, surgical trauma or radiation damage.

Overflow Bladder

Overflow bladder incontinence occurs because of urine retention with bladder distention. Urine accumulates in the bladder until maximum bladder capacity is reached. It then leaks through the urethra by “overflow,” usually manifesting as dribbling. However, increased intra-abdominal pressure may also cause loss of urine, so that overflow incontinence sometimes mimics stress incontinence.

In addition, overflow incontinence can be caused by underactive bladder contractions secondary to medications that relax the bladder detrusor muscle (e.g., anticholinergic agents, calcium channel blockers). It can also be caused by denervation of the detrusor resulting from a neurologic abnormality that affects bladder innervation (e.g., diabetic neuropathy) or because of damage to bladder innervation (e.g., tumors, radiation, surgery). Finally, overflow bladder can be caused by obstructed urinary outflow resulting from prostate enlargement, fecal impaction, urethral stricture or urethral constriction related to alpha-adrenergic agonist medications.

Evaluation of Incontinence

Keeping urge, stress and overflow incontinence in mind, family physicians can undertake the basic evaluation of patients with incontinence. In most patients, the evaluation requires only a medical history, a physical examination, urinalysis and measurement of postvoid residual (PVR) urine volume. Occasionally, simple office tests of lower urinary tract function are helpful. The AHCPR guideline panel concluded that sophisticated tests such as cystoscopy and imaging studies, and formal urodynamic studies like cystometrography are not routinely required to evaluate incontinence.1

The first goal of the basic evaluation is to identify transient (i.e., easily reversible) causes of incontinence so that effective treatments can be instituted. The second goal is to identify conditions that may require special evaluation or referral to a urologist or a urogynecologist. After transient causes and indications for special evaluation or referral have been excluded, the third goal is to decide if the patient's symptoms are more indicative of urge incontinence or stress incontinence and initiate treatment accordingly (Figure 1).1 If treatments are ineffective, the patient should then undergo a more specialized evaluation.

FIGURE 1.

Diagnostic algorithm for evaluating urinary incontinence in primary care practice. The algorithm is an adaptation of the approach recommended in the AHCPR guideline for diagnosis and management of urinary incontinence.

View Large


FIGURE 1.

Diagnostic algorithm for evaluating urinary incontinence in primary care practice. The algorithm is an adaptation of the approach recommended in the AHCPR guideline for diagnosis and management of urinary incontinence.


FIGURE 1.

Diagnostic algorithm for evaluating urinary incontinence in primary care practice. The algorithm is an adaptation of the approach recommended in the AHCPR guideline for diagnosis and management of urinary incontinence.

Transient causes are responsible in about one half of hospitalized patients with incontinence and about one third of incontinent persons in the community.14  Some of these causes are listed in Table 2. If none of these conditions is identified or suspected after a history, physical examination, urinalysis and PVR urine volume determination, the incontinence probably does not have a transient cause.

TABLE 2

Transient (Reversible) Conditions That Cause or Contribute to Urinary Incontinence

Condition or finding Management

Detectable by history

Drug side effects (see Table 4)

Discontinue or change medication, if possible

Delirium or hypoxia

Treat underlying cause

Recent prostatectomy

Behavioral therapy

Excessive fluid intake

Reduction of fluid intake

Impaired mobility

Therapy or environmental changes (e.g., bedside commode)

Detectable by physical examination

Atrophic vaginitis

Estrogen therapy

Fecal impaction

Disimpaction and stool softeners

Detectable by urinalysis

Urinary tract infection

Antibiotic therapy

Glycosuria

Control diabetes

TABLE 2   Transient (Reversible) Conditions That Cause or Contribute to Urinary Incontinence

View Table

TABLE 2

Transient (Reversible) Conditions That Cause or Contribute to Urinary Incontinence

Condition or finding Management

Detectable by history

Drug side effects (see Table 4)

Discontinue or change medication, if possible

Delirium or hypoxia

Treat underlying cause

Recent prostatectomy

Behavioral therapy

Excessive fluid intake

Reduction of fluid intake

Impaired mobility

Therapy or environmental changes (e.g., bedside commode)

Detectable by physical examination

Atrophic vaginitis

Estrogen therapy

Fecal impaction

Disimpaction and stool softeners

Detectable by urinalysis

Urinary tract infection

Antibiotic therapy

Glycosuria

Control diabetes

Conditions requiring specialized evaluations (Table 3) are relatively uncommon in primary care practice. The diagnosis and treatment of incontinence may not be straightforward when these conditions are present. Frequently, patients with such conditions require evaluation by a urologist or urogynecologist.

TABLE 3

Indications for Special Evaluation or Referral of Patients with Incontinence

Conditions detected by history

Recent onset (within two months) of urge incontinence or irritative bladder symptoms

Previous anti-incontinence surgery

Previous radical pelvic surgery

Incontinence associated with recurrent symptomatic urinary infections

Conditions detected by physical examination

Prostate nodule or asymmetry

Gross pelvic prolapse (beyond hymen)

Neurologic abnormality suggesting systemic disorder or spinal cord lesion

Conditions detected by urinalysis

Hematuria without infection

Significant persistent proteinuria

Others situations that arise or are detected during or after the basic evaluation

Abnormal postvoid residual urine volume

Inability to arrive at a presumptive diagnosis or treatment plan

Failure to respond to treatment of presumptive diagnosis

Consideration of surgical intervention


Information from reference 1.

TABLE 3   Indications for Special Evaluation or Referral of Patients with Incontinence

View Table

TABLE 3

Indications for Special Evaluation or Referral of Patients with Incontinence

Conditions detected by history

Recent onset (within two months) of urge incontinence or irritative bladder symptoms

Previous anti-incontinence surgery

Previous radical pelvic surgery

Incontinence associated with recurrent symptomatic urinary infections

Conditions detected by physical examination

Prostate nodule or asymmetry

Gross pelvic prolapse (beyond hymen)

Neurologic abnormality suggesting systemic disorder or spinal cord lesion

Conditions detected by urinalysis

Hematuria without infection

Significant persistent proteinuria

Others situations that arise or are detected during or after the basic evaluation

Abnormal postvoid residual urine volume

Inability to arrive at a presumptive diagnosis or treatment plan

Failure to respond to treatment of presumptive diagnosis

Consideration of surgical intervention


Information from reference 1.

The following sections review the components of the basic evaluation of incontinence. As noted in Figure 1, these components are the history, the physical examination, urinalysis and measurement of PVR urine volume.

History

The patient's medical history can be helpful in identifying transient incontinence caused by medication side effects, prostatectomy and medical conditions with central nervous system dysfunction or impaired mobility. Of these, medication side effects are probably the most important causes of transient incontinence (Table 4). If the medication can be discontinued or changed, incontinence may improve. Incontinence sometimes occurs after transurethral resection of the prostate. This urge incontinence, which may persist for a variable period of time, may be alleviated with behavioral therapies.15  A more complete list of transient conditions that can be detected or suspected based on the medical history is provided in Table 2. Suggested treatments for these conditions are also included.

TABLE 4

Drugs That Can Cause or Contribute to Urinary Incontinence

Drug class Mechanism of incontinence

Drugs causing overflow incontinence

Anticholinergics

Antidepressants

Decreased bladder contractions with retention

Antipsychotics

Decreased bladder contractions with retention

Sedative-hypnotics

Decreased bladder contractions with retention

Antihistamines

Decreased bladder contractions with retention

Nervous system depressants

Narcotics

Decreased bladder contractions with retention

Alcohol

Decreased bladder contractions with retention

Calcium channel blockers

Decreased bladder contractions with retention

Alpha-adrenergic agonists

Sphincter contraction with outflow obstruction

Beta-adrenergic blockers

Sphincter contraction with outflow obstruction

Drugs causing stress incontinence

Alpha-adrenergic antagonists

Sphincter relaxation with urinary leakage

Drugs causing urge incontinence

Diuretics

Contractions stimulated by high urine flow

Caffeine

Diuretic effect

Sedative-hypnotics

Depressed central inhibition of micturition

Alcohol

Diuretic effect and depressed central inhibition

TABLE 4   Drugs That Can Cause or Contribute to Urinary Incontinence

View Table

TABLE 4

Drugs That Can Cause or Contribute to Urinary Incontinence

Drug class Mechanism of incontinence

Drugs causing overflow incontinence

Anticholinergics

Antidepressants

Decreased bladder contractions with retention

Antipsychotics

Decreased bladder contractions with retention

Sedative-hypnotics

Decreased bladder contractions with retention

Antihistamines

Decreased bladder contractions with retention

Nervous system depressants

Narcotics

Decreased bladder contractions with retention

Alcohol

Decreased bladder contractions with retention

Calcium channel blockers

Decreased bladder contractions with retention

Alpha-adrenergic agonists

Sphincter contraction with outflow obstruction

Beta-adrenergic blockers

Sphincter contraction with outflow obstruction

Drugs causing stress incontinence

Alpha-adrenergic antagonists

Sphincter relaxation with urinary leakage

Drugs causing urge incontinence

Diuretics

Contractions stimulated by high urine flow

Caffeine

Diuretic effect

Sedative-hypnotics

Depressed central inhibition of micturition

Alcohol

Diuretic effect and depressed central inhibition

The medical history can also help physicians identify conditions that require specialized evaluation or referral (Table 3). Such conditions include previous anti-incontinence surgery, previous radical pelvic surgery, incontinence associated with recurrent symptomatic urinary infections and recent onset (within two months) of urge incontinence caused by irritative bladder symptoms, which may indicate bladder neoplasm and require cystoscopy for evaluation.

If the history does not suggest a transient cause for incontinence or provide reasons for specialized evaluation, the patient should be asked specific questions directed at distinguishing the symptoms of stress incontinence from those of urge incontinence.

The principal symptom of urge incontinence is loss of urine associated with a strong desire to void (i.e., urgency). The patient may also complain about needing to void at frequent intervals or being unable to get to a bathroom quickly enough after first feeling the urge to void. Patients with urge incontinence often have the sensation that their bladder has not fully emptied after urination.

Symptoms of stress incontinence include momentary leakage of urine with sneezing, coughing, laughing or other actions that increase intra-abdominal pressure. The loss of urine occurs when the bladder is full or partly full, and it stops when intra-abdominal pressure returns to normal (i.e., sustained urination does not occur). Sustained leakage of urine in situations such as coughing suggests “pseudo” stress incontinence, which is actually a manifestation of urge incontinence. With this form of incontinence, an irritable, poorly inhibited bladder is stimulated to contract by repetitive transient increases in intra-abdominal pressure from coughing or other actions. Formal urodynamic tests may be needed to diagnose pseudo stress incontinence.12

Physical Examination

The initial physical examination should focus on finding fecal impaction or atrophic vaginitis, both of which are potentially reversible causes of urinary incontinence. In patients with fecal impaction, a mass of stool in the rectum puts extrinsic pressure on the urethra, with resultant obstruction and overflow incontinence. Disimpaction may relieve incontinence. Atrophic vaginitis causes urinary incontinence because, in many women, the estrogen-sensitive mucosa of the vagina extends into the urethra and bladder trigone. If atrophic vaginitis is present, atrophic urethritis and trigonitis may also be present, with the three conditions causing inflammation-induced bladder contractions. Topical or systemic estrogen is the usual treatment.

Physical findings that warrant referral or specialized testing include prostate nodules or asymmetry, gross pelvic prolapse (beyond the hymen) and abnormalities suggesting systemic neurologic disorders or a spinal cord lesion.

While the physical examination may suggest a transient cause for urinary incontinence or reasons for specialized testing, it cannot distinguish between urge and stress incontinence. Although findings such as cystocele suggest the possibility of stress incontinence, they are not specific for this problem. Urge incontinence has no specific physical findings.

Urinalysis

Urinalysis can identify acute urinary tract infection and diabetes-induced glycosuria, both of which can cause or aggravate urge incontinence. These conditions are reversible with treatment. If appropriate, a urine culture should also be obtained.

Postvoid Residual Urine Volume

As part of the basic evaluation of urinary incontinence, all patients should undergo measurement of PVR urine volume to detect urinary retention (i.e., overflow bladder). PVR volume measurement can detect retention caused by potentially reversible factors (e.g., anticholinergic or other drugs, fecal impaction). Urinary retention not obviously resulting from a transient cause generally requires specialized evaluations, including cystometrography, to determine why the bladder does not empty properly.

The PVR urine volume can be measured by one of two methods. The first and most common method is “in and out” urethral catheterization within a few minutes after the patient has urinated to empty the bladder. The quantity of urine obtained is noted. PVR volume can also be measured with pelvic ultrasonography, using portable devices designed for office use.16 Ultrasonography is a useful alternative to catheterization, especially for measuring the PVR volume in men with suspected prostate obstruction, because catheterizing these patients may cause urinary infection or obstruction.

Normally, less than 50 mL of residual urine is present after voiding. Volumes of more than 200 mL are abnormal. Intermediate volumes (50 to 200 mL) are considered equivocal, and the test should be repeated. Clinical judgment is needed to interpret repeatedly equivocal results.

Simple Tests of Lower Urinary Tract Function

Sometimes the basic evaluation reveals neither transient causes nor indications for specialized testing, and the history and physical examination do not permit distinction between urge and stress incontinence. In this situation, simple tests of lower urinary tract function may be helpful. These tests mimic formal cystometrographic studies but can easily be performed in the family physician's office.

Office Cystometry

Simple office cystometry is a test for urge incontinence.17 In this test, a French nonballooned urinary catheter, no. 12 to no. 14, is inserted into the bladder. Catheterization can be performed at the same time that PVR urine volume is measured.

After the bladder empties, the plunger is removed from a bayonet-tipped 50-mL syringe, and the tip is inserted into the end of the catheter (Figure 2). With the physician holding the center of the syringe about 15 cm above the urethra, 50 mL of sterile water is poured into the open end of the syringe and allowed to flow into the bladder. Keeping track of the total amount of water used, the physician continues to instill water in 50-mL increments until the patient experiences the urge to urinate.

FIGURE 2.

Simple office cystometry. A nonballooned catheter is placed in the patient's bladder, and a 50-mL syringe (with plunger removed) is inserted into the open end of the catheter. The center of the syringe is held in position 15 cm above the symphysis pubis. Sterile water is instilled into the bladder until the patient reports feeling a strong urge to void or until bladder contractions occur. Contractions are detected by observing movement of the fluid level in the syringe.

View Large


FIGURE 2.

Simple office cystometry. A nonballooned catheter is placed in the patient's bladder, and a 50-mL syringe (with plunger removed) is inserted into the open end of the catheter. The center of the syringe is held in position 15 cm above the symphysis pubis. Sterile water is instilled into the bladder until the patient reports feeling a strong urge to void or until bladder contractions occur. Contractions are detected by observing movement of the fluid level in the syringe.


FIGURE 2.

Simple office cystometry. A nonballooned catheter is placed in the patient's bladder, and a 50-mL syringe (with plunger removed) is inserted into the open end of the catheter. The center of the syringe is held in position 15 cm above the symphysis pubis. Sterile water is instilled into the bladder until the patient reports feeling a strong urge to void or until bladder contractions occur. Contractions are detected by observing movement of the fluid level in the syringe.

At this point, water instillation is continued in 25-mL increments until the patient experiences severe urgency (“I can't hold it anymore”) or bladder contractions occur. Contractions are detected by monitoring the fluid level that appears in the syringe after several aliquots of water have been instilled. A rise and fall in the fluid level indicates pressure changes (i.e., contractions) within the bladder.

Severe urgency or bladder contractions at less than 300 mL of bladder volume constitute a presumptive diagnosis of urge incontinence. For the diagnosis of urge incontinence, simple cystometry has a 75 to 100 percent sensitivity, a 69 to 89 percent specificity, and a 74 to 91 percent positive predictive value, using formal multichannel cystometrography as the gold-standard comparison.17

Office Stress Testing

Several maneuvers can be used in conjunction with simple cystometry to test for stress incontinence in women.17 These maneuvers can be performed immediately after the bladder is filled during simple cystometry, and after the catheter is removed. The patient lies supine on the examination table with a full bladder and coughs forcefully. The physician places a gauze pad in front of the perineum. If urine leaks onto the gauze pad during coughing, a presumptive diagnosis of stress incontinence is made. Next, the physician places his or her fingers on either side of the patient's urethra and elevates the structure. The patient is then asked to cough. In patients with stress incontinence, urethral elevation prevents further urine leakage.

If no incontinence is demonstrated in the supine position, the maneuvers should be repeated with the patient in a standing position.18 If no incontinence occurs in either position, the patient probably does not have stress incontinence.

Putting it all Together

Treating the Presumptive Diagnosis

If the basic evaluation identifies transient causes of incontinence, these causes should be treated (Table 2). Similarly, if the basic evaluation reveals reasons for referral or specialized testing (Table 3), these measures should be undertaken.

If neither of the above situations occurs and the physician can make a presumptive diagnosis of stress or urge incontinence (if necessary, by performing simple tests of lower urinary tract function), appropriate treatments can be instituted. While a detailed discussion of treatments for urinary incontinence is beyond the scope of this article, the basic treatments are outlined in Table 5.19,20 In general, behavioral therapies are first-choice treatments. For urge incontinence in particular, behavioral therapies are the most effective treatments available.1,19 Medication is used secondarily, often as an adjunct to behavioral treatments. Surgical interventions are an option in properly selected patients, especially those with stress incontinence.

TABLE 5

Common Treatments for Urinary Incontinence*

Urge incontinence

First-line treatment: behavioral therapies such as bladder training and bladder drill19

Second-line treatment: medications such as oxybutynin (Ditropan) or imipramine (Tofranil)

Third-line treatment: surgical procedures (rarely used)

Stress incontinence

First-line treatment: behavioral therapies such as Kegel's exercise and bladder training

Second-line treatment: medications such as alpha-adrenergic drugs and/or estrogen

Third-line treatment: surgical procedures†

Overflow incontinence

First-line treatment: intermittent catheterization

Second-line treatment: indwelling catheterization

Third-line treatment: suprapubic catheterization

Nonoverflow urinary incontinence (sometimes used)

Pessaries

Electric stimulation devices

Surgically implantable artificial sphincters

Periurethral bulking injections

Penile compression devices

Biofeedback

Vaginal cones

Intraurethral inserts20


*—Suggested first-, second- and third-line treatments may not be applicable in all patients. Clinical judgment, along with a patient's medical condition, cognition and choice, should always be considered.

†—Because surgical treatments for stress incontinence are so much more effective than behavioral therapies and/or medications, many experts recommend surgical treatments as first-line therapy for stress incontinence in patients who are suitable candidates for surgery and who are proved by formal cystometric testing to have stress incontinence.

‡—Note that before overflow incontinence is treated with catheterization, the patient should undergo thorough evaluation to identify the cause of retained urine (i.e., increased postvoid residual urine volume) and to exclude conditions that require surgical or other interventions, such as benign prostatic hyperplasia (see Table 3).

TABLE 5   Common Treatments for Urinary Incontinence*

View Table

TABLE 5

Common Treatments for Urinary Incontinence*

Urge incontinence

First-line treatment: behavioral therapies such as bladder training and bladder drill19

Second-line treatment: medications such as oxybutynin (Ditropan) or imipramine (Tofranil)

Third-line treatment: surgical procedures (rarely used)

Stress incontinence

First-line treatment: behavioral therapies such as Kegel's exercise and bladder training

Second-line treatment: medications such as alpha-adrenergic drugs and/or estrogen

Third-line treatment: surgical procedures†

Overflow incontinence

First-line treatment: intermittent catheterization

Second-line treatment: indwelling catheterization

Third-line treatment: suprapubic catheterization

Nonoverflow urinary incontinence (sometimes used)

Pessaries

Electric stimulation devices

Surgically implantable artificial sphincters

Periurethral bulking injections

Penile compression devices

Biofeedback

Vaginal cones

Intraurethral inserts20


*—Suggested first-, second- and third-line treatments may not be applicable in all patients. Clinical judgment, along with a patient's medical condition, cognition and choice, should always be considered.

†—Because surgical treatments for stress incontinence are so much more effective than behavioral therapies and/or medications, many experts recommend surgical treatments as first-line therapy for stress incontinence in patients who are suitable candidates for surgery and who are proved by formal cystometric testing to have stress incontinence.

‡—Note that before overflow incontinence is treated with catheterization, the patient should undergo thorough evaluation to identify the cause of retained urine (i.e., increased postvoid residual urine volume) and to exclude conditions that require surgical or other interventions, such as benign prostatic hyperplasia (see Table 3).

Mixed Incontinence

At times, patients have symptoms or findings suggesting both stress and urge incontinence. When mixed incontinence is identified, the physician should treat the type of incontinence for which symptoms predominate (i.e., stress or urge incontinence).

When No Presumptive Diagnosis Can Be Made

If no presumptive diagnosis can be made, the patient should undergo a more sophisticated evaluation. Useful tests include formal multichannel or subtracted cystometrography, urine flowmetry, urethral pressure profiles and urethral sphincter electromyography.21 Endoscopic and imaging tests may be helpful in selected patients. These tests are usually conducted by a urologist or urogynecologist.

Treatment Failure

If a presumptive diagnosis is identified and treated, the patient should be monitored for improvement. If the desired clinical result does not occur, the patient should undergo further evaluation to ensure that the presumptive diagnosis was correct and that prescribed treatments are optimal. More sophisticated tests may reveal an unsuspected basis for the patient's incontinence and thereby further dictate treatment.

In some patients who have not responded to treatment, further testing reveals that the presumptive diagnosis was correct but the appropriate treatments were simply ineffective in alleviating the incontinence. When this occurs, the patient may be managed with various measures, including pads, adult artificial sphincters and, in some situations, intermittent or indwelling urethral catheterization.

The Author

BARRY D. WEISS, M.D., is professor and chairman of the Department of Family Practice at the University of Texas Health Science Center in San Antonio. He is also the editor of Family Medicine, the journal of the Society of Teachers of Family Medicine. Dr. Weiss served on the consensus panel of the U.S. Agency for Health Care Policy and Research (AHCPR), which developed the 1996 AHCPR practice guideline on urinary incontinence.

Address correspondence to Barry D. Weiss, M.D., Department of Family Practice, University of Texas Health Science Center in San Antonio, 7703 Floyd Curl Dr., Suite 610-L, San Antonio, TX 78284-7794. Reprints are not available from the author.


Figure 1 is adapted from Fantl JA, Newman DK, Colling J, et al. Urinary incontinence in adults: acute and chronic management. Clinical Practice Guideline no. 2, 1996 update. Rockville, Md.: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, March 1996. AHCPR publication no. 96-0682.

REFERENCES

1. Fantl JA, Newman DK, Colling J, et al. Urinary incontinence in adults: acute and chronic management. Clinical Practice Guideline no. 2, 1996 update. Rockville, Md.: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, March 1996. AHCPR publication no. 96-0682.

2. Burgio K, Matthews KA, Engel BT. Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women. J Urol. 1991;146:1255–9.

3. Noelker L. Incontinence in elderly cared for by family. Gerontologist. 1987;27:194–200.

4. Herzog AR, Fultz NH. Prevalence and incidence of urinary incontinence in community-dwelling populations. J Am Geriatr Soc. 1990;38:273–81.

5. Palmer MH, German PS, Ouslander JG. Risk factors for urinary incontinence one year after nursing home admission. Res Nurs Health. 1991;14:405–12.

6. Division of Chronic Disease Control and Community Intervention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control. Urinary incontinence among hospitalized persons aged 65 years and older—United States, 1984–1987. MMWR Morb Mortal Wkly Rep. 1991;40:433–6.

7. Burgio KL, Ives DG, Locher JL, Arena VC. Treatment seeking for urinary incontinence in adults. J Am Geriatr Soc. 1994;42:208–12.

8. Mitteness LS. Knowledge and beliefs about urinary incontinence in adulthood and old age. J Am Geriatr Soc. 1990;38:374–8.

9. Wyman JF, Harkins SW, Fantl JA. Psychosocial impact of urinary incontinence in the community-dwelling population. J Am Geriatr Soc. 1990;38:282–8.

10. Hu T. The economic impact of urinary incontinence on health-care costs. J Am Geriatr Soc. 1990;38:292–5.

11. McDowell JB, Engberg SJ, Rodriguez E, Engberg R, Sereika S. Characteristics of urinary incontinence in homebound older adults. J Am Geriatr Soc. 1996;44:963–8.

12. Diokno AC, Wells TJ, Brink CA. Urinary incontinence in elderly women: urodynamic evaluation. J Am Geriatr Soc. 1987;35:940–6.

13. Fantl JA, Wyman JF, McClish DK, Bump RC. Urinary incontinence in community-dwelling women: clinical, urodynamic and severity characteristics. Am J Obstet Gynecol. 1990;162:946–51.

14. Resnick NM. Initial evaluation of the incontinent patient. J Am Geriatr Soc. 1990;38:311–6.

15. Burgio KL, Stutzman RE, Engel BT. Behavioral training for post-prostatectomy urinary incontinence. J Urol. 1989;141:303–6.

16. Coombes GM, Millard RJ. The accuracy of portable ultrasound scanning in the measurement of residual urine volume. J Urol. 1994;152:2083–5.

17. Fonda D, Brimage PJ, D'Astoli M. Simple screening for urinary incontinence in the elderly: comparison of simple and multichannel cystometry. Urology. 1993;42:536–40.

18. Kadar N. The value of bladder filling in the clinical detection of urine loss and selection of patients for urodynamic testing. Br J Obstet Gynaecol. 1988;95:698–704.

19. Weiss BD. Nonpharmacologic treatment of urinary incontinency. Am Fam Physician. 1991;44:579–86.

20. Miller JL, Bavendam T. Treatment with the Reliance control insert: one-year experience. J Endourol. 1996;10:287–92.

21. Diokno AC. Diagnostic categories of incontinence and the role of urodynamic testing. J Am Geriatr Soc. 1990;38:300–5.

Each year members of a different family practice department develop articles for “Problem-Oriented Diagnosis.” This series is coordinated by the Department of Family Practice at the University of Texas Health Science Center at San Antonio. Guest editors of the series are David A. Katerndahl, M.D., and Clinton Colmenares.


Copyright © 1998 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

More in AFP

More in Pubmed

Navigate this Article